Study of the interferon profile in children with bronchial asthma
https://doi.org/10.53529/2500-1175-2025-3-66-73
Abstract
Introduction. Bronchial asthma in children is an urgent medical problem. Currently, there are separate clusters of BA variants and various phenotypes. ARVI is the most frequent trigger of BA exacerbations, which makes the study of interferon status relevant.
Methods. A study of IFN-α and IFN-γ in the blood serum of children with AIBA (n = 60) and VIBA (n = 10).
Results. An increase in IFN-γ was found in AIBA by 1.9 times and in VIBA by 1.7 times. An increase in IFN-α was observed in both AIBA (4.7 times, 2.95 ± 0.73 pg/ml) and VIBA (9.9 tim es, 6.24 ± 1.32 pg/ml). A decrease in IFN-γ in the blood serum was observed in moderate AIBA (1.23 ± 1.59 pg/ml) and severe AIBA (0.76 ± 0.64 pg/ml).
Conclusion. Decreased IFN-γ content is an important factor in the severe course of AIB. As an additional marker for the diagnosis of BA phenotype, the use of IFN-α / IFN-γ ratio is proposed.
About the Authors
I. N. SerdinskayaRussian Federation
Inna Nikolaevna Serdinskaya, pediatrician
420133; Adoratsky str., 6; Kazan
Kh. M. Vakhitov
Russian Federation
Khakim Muratovich Vakhitov, Dr. Sci., Professor
Department of Hospital Pediatrics
420012; Butlerova str., 49; Kazan
E. V. Agafonova
Russian Federation
Elena Valentinovna Agafonova, Cand. Sci., Associate Professor, Head clinical and diagnostic laboratory
Department of Propaedeutics of Childhood Diseases and Faculty Pediatrics
420015; B. Krasnaya str., 67; Kazan
References
1. Geppe N.A., Kondyurina E.G., Revyakina V.A., Malakhov A.B., Kolosova N.G. Therapy of Bronchial Asthma in Children: Age Aspects. Pediatrics. Consilium Medicum. 2021; 2: 113–122. (In Russ.) doi: 10.26442/26586630.2021.2.200928.
2. Abbafati C., Abbas K.M., Abbasi M., Abbasifard M., Abbasi-Kangevari M., Abbastabar H., Abd-Allah F., Abdelalim A., Abdollahi M., Abdollahpour I., Abedi A., Abedi P., Abegaz K.H., Abolhassani H., Abosetugn A.E., Aboyans V., Abrams E.M., Abreu L.G., Abrigo M.R.M., Murray C.J.L. 2020. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England), 396 (10258), 1204 1222. doi: 10.1016/S0140-6736(20)30925-9.
3. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION Updated 2020. www.ginasthma.org
4. Most Recent Asthma Data | CDC. (n.d.). Retrieved February 9, 2024, from https://www.cdc.gov/asthma/most_recent_data.htm.
5. Nenasheva N.M. Clinical Phenotypes of Atopic Bronchial Asthma: Diagnosis and Treatment. Palmarium Academic Publishing, 2012, 319 p. (n.d.). Retrieved February 9, 2024. (In Russ.) from https://bookmix.ru/book.phtml?id=2271191.
6. GINA Main Report 2023 Front Cove. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2023. [Electronic resource], 10. 06. 2023. URL: http://www.ginasthma.org/.
7. Ray A., Camiolo M., Fitzpatrick A., Gauthier M., & Wenzel S. E. (2020). Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma? Physiological Reviews. 100 (3): 983–1017. doi: 10.1152/PHYSREV.00023.2019.
8. Moore W.C., Meyers D.A., Wenzel S.E., Teague W.G., Li H., Li X., D’Agostino R., Castro M., Curran-Everett D., Fitzpatrick A.M., Gaston B., Jarjour N.N., Sorkness R., Calhoun W.J., Chung K.F., Comhair S.A.A., Dweik R.A., Israel E., Peters S.P., Bleecker E.R. (2010). Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. American Journal of Respiratory and Critical Care Medicine. 181 (4): 315–323. doi: 10.1164/RCCM.200906-0896OC.
9. Khaitov R.M. (2009). Allergology and Immunology: National Guidelines / Ed. by R.M. Khaitov and N.I. Ilyina. Moscow: GEOTAR-Media, 2009. 656 p. (In Russ.)
10. Bronchial asthma: clinical guidelines, 2024. 193 p. Access: pediatr-russia.ru (accessed on 16. 04. 2025). (In Russ.)
11. Nenasheva N.M. Bronchial asthma. A modern view of the problem. Moscow: GEOTAR-Media, 2018. 303 p. (In Russ.)
12. Vilcek J. Novel interferons. Nat Immunol. 2003 Jan; 4 (1): 8–9. doi: 10.1038/ni0103-8. PMID: 12496969.
13. Hansel T.T., Tunstall T., Trujillo-Torralbo M.B., et al. A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13). EBioMedicine. 2017; 19: 128–138. doi: 10.1016/j.ebiom.2017.03.033.
14. Huber J.P., Ramos H.J., Gill M.A., Farrar J.D. Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J. Immunol. 2019; 185 (2): 813–817.
15. Bush A. (2018). Management of asthma in children. Minerva Pediatrica. 70 (5): 444–457. doi: 10.23736/S0026-4946.18.05351-3.
16. Vishneva E.A., Namazova-Baranova L.S., Selimzyanova L.R., Alekseeva A.A., Novik G.A., Efendieva K.E., Levina Yu.G., Dobrynina E.A. Current tactics of managing children with bronchial asthma // Pediatric pharmacology. 2017; 14 (6): 443–458. (In Russ.) doi: 10.15690/pf.v14i6.1828.
17. Latysheva T.V., Medunitsyna E.N. Infectious diseases of the respiratory tract in patients with bronchial asthma. BC. 2007; 7: 60. (In Russ.) https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Infek…atelynogo_trakta_u_bolynyh_s_bronhialynoy_astmoy/.
18. Martin J., Townshend J., & Brodlie M. (2022). Diagnosis and management of asthma in children. BMJ Paediatrics Open. 6 (1). doi: 10.1136/BMJPO-2021-001277.
19. Custovic A., Belgrave D., Lin L., et al. Cytokine Responses to Rhinovirus and Development of Asthma, Allergic Sensitization, and Respiratory Infections during Childhood. Am J Respir Crit Care Med. 2018; 197 (10): 1265–1274. doi: 10.1164/rccm.201708-1762OC.
Review
For citations:
Serdinskaya I.N., Vakhitov Kh.M., Agafonova E.V. Study of the interferon profile in children with bronchial asthma. Allergology and Immunology in Paediatrics. 2025;(3):66-73. (In Russ.) https://doi.org/10.53529/2500-1175-2025-3-66-73